Viewing Study NCT06735820

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2026-03-01 @ 10:10 AM
Study NCT ID: NCT06735820
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-03
First Post: 2024-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST
Sponsor: AeRang Kim
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Peripheral Nerve Sheath Tumor (MPNST) View
None Neurofibromatosis 1 (NF1) View
None Atypical Neurofibroma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NF1 View
None MPNST View
None MEK inhibitor View
None MDM2 inhibitor View
None atypical neurofibroma View
None ANNUBP View